他汀依从性与动脉粥样硬化性心血管疾病患者死亡率的相关性
与MPR≥90%者相比,MPR<50%者全因死亡风险调整后HR为1.30(95%CI 1.27-1.34)。女性、少数族裔及年轻和年长患者依从性较低。
要点
- 他汀低依从性(MPR<50%)与ASCVD患者全因死亡风险升高独立相关。
- 女性、少数族裔、年轻及年长患者他汀依从性较低,需重点关注。
- 研究提示应寻找改善他汀依从性的方法以降低死亡风险。
核心结论
- 在ASCVD患者中,他汀治疗低依从性与更高的全因死亡风险相关。
- 女性、少数族裔、年轻和年长患者更不易坚持他汀治疗。
主要发现
- 与MPR≥90%者相比,MPR<50%者调整后全因死亡HR为1.30(95%CI 1.27-1.34)。
- MPR 50%-69%者HR为1.21(95%CI 1.18-1.24),MPR 70%-89%者HR为1.08(95%CI 1.06-1.09)。
- 中等强度他汀治疗者较高强度治疗者更依从(OR 1.18;95%CI 1.16-1.20)。
- 女性依从性较低(OR 0.89;95%CI 0.84-0.94),少数族裔亦较低。
临床怎么用
- 对ASCVD患者应常规评估他汀依从性,尤其关注女性、少数族裔及年轻和年长人群。
- 低依从性(如MPR<50%)提示死亡风险升高,需采取干预改善依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Statins decrease mortality in those with atherosclerotic cardiovascular disease (ASCVD), but statin adherence remains suboptimal. OBJECTIVE: To determine the association between statin adherence and mortality in patients with ASCVD who have stable statin prescriptions. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort analysis included patients who were between ages 21 and 85 years and had 1 or more International Classification of Diseases, Ninth Revision, Clinical Modification codes for ASCVD on 2 or more dates in the previous 2 years without intensity changes to their statin prescription who were treated within the Veterans Affairs Health System between January 1, 2013, and April 2014. EXPOSURES: Statin adherence was defined by the medication possession ratio (MPR). Adherence levels were categorized as an MPR of less than 50%, 50% to 69%, 70% to 89%, and 90% or greater. For dichotomous analyses, adherence was defined as an MPR of 80% or greater. MAIN OUTCOMES AND MEASURES: The primary outcome was death of all causes adjusted for demographic and clinical characteristics, as well as adherence to other cardiac medications. RESULTS: Of 347 104 eligible adults with ASCVD who had stable statin prescriptions, 5472 (1.6%) were women, 284 150 (81.9%) were white, 36 208 (10.4%) were African American, 16 323 (4.7%) were Hispanic, 4093 (1.2%) were Pacific Islander, 1293 (0.4%) were Native American, 1145 (0.3%) were Asian, and 1794 (0.5%) were other races. Patients taking moderate-intensity statin therapy were more adherent than patients taking high-intensity statin therapy (odds ratio [OR], 1.18; 95% CI, 1.16-1.20). Women were less adherent (OR, 0.89; 95% CI, 0.84-0.94), as were minority groups. Younger and older patients were less likely to be adherent compared with adults aged 65 to 74 years. During a mean (SD) of 2.9 (0.8) years of follow-up, there were 85 930 deaths (24.8%). Compared with the most adherent patients (MPR ≥ 90%), patients with an MPR of less than 50% had a hazard ratio (HR; adjusted for clinical characteristics and adherence to other cardiac medications) of 1.30 (95% CI, 1.27-1.34), those with an MPR of 50% to 69% had an HR of 1.21 (95% CI, 1.18-1.24), and those with an MPR of 70% to 89% had an HR of 1.08 (95% CI, 1.06-1.09). CONCLUSIONS AND RELEVANCE: Using a national sample of Veterans Affairs patients with ASCVD, we found that a low adherence to statin therapy was associated with a greater risk of dying. Women, minorities, younger adults, and older adults were less likely to adhere to statins. Our findings underscore the importance of finding methods to improve adherence.
引用
- Rodriguez F, Maron DJ, Knowles JW, et al. Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease. JAMA Cardiol. 2019. PMID: 30758506. doi:10.1001/jamacardio.2018.4936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。